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Introduction
Two main neurogenic regions are present in the postnatal mouse 
forebrain: the rostral subependymal zone of the lateral ventricle, 
the so-called subventricular zone (SVZ), and the subgranular 
layer of the hippocampal dentate gyrus (Luskin, 1993; Lois and 
Alvarez-Buylla, 1994; Morshead et al., 1998). In these regions, 
cell divisions continue to take place throughout life, as complex 
interactions between intrinsic molecular programs and extrinsic 
determinants induce neural stem cells and progenitors to prolif-
erate, differentiate, and undergo apoptotic cell death. Signifi  cant 
progress has been recently made in the identifi  cation of extra-
cellular factors that regulate neural stem cells and progenitor pro-
liferation and differentiation in the SVZ (Conover et al., 2000; 
Coskun and Luskin, 2002; Doetsch et al., 2002; Lai et al., 2003; 
Molofsky et al., 2003; Anton et al., 2004; Leone et al., 2005; 
Ghashghaei et al., 2006; Lledo et al., 2006; Meng et al., 2006; 
  Ricard et al., 2006). However, several lines of evidence also indi-
cate that neural progenitor proliferation is intrinsically controlled 
by a molecular network of kinases and accessory proteins.
Cell cycle progression from G1 to S phase is positively 
regulated by (a) Cdks (Cdk2, 4, and 6), which are activated upon 
binding of the specifi  c regulatory subunits (cyclin E, D, and A, 
respectively; Morgan, 1997), and (b) phosphorylation of their 
target retinoblastoma protein (Rb), which causes the release of 
E2F1-4 transcription factors (Mittnacht, 1998; Knudsen and 
Knudsen, 2006). Additionally, the Cdk inhibitors p19
INK4d, 
p21
Cip1, and p27
Kip1 function as negative regulators of prolifera-
tion in the SVZ (Durand et al., 1998; Casaccia-Bonnefi  l et al., 
1999; Ghiani et al., 1999; Coskun and Luskin, 2002; Doetsch 
et al., 2002). Possible changes in the role and function of these 
intrinsic regulators during postnatal development of neural pro-
genitors are still largely unexplored but are likely to play a ma-
jor role in modifying the proliferation rate of SVZ progenitors 
between birth and adulthood.
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e investigated the function of cyclin-dependent 
kinase 2 (Cdk2) in neural progenitor cells dur-
ing postnatal development. Chondroitin sul-
fate proteoglycan (NG2)–expressing progenitor cells of 
the subventricular zone (SVZ) show no signiﬁ  cant differ-
ence in density and proliferation between Cdk2
−/− and 
wild-type mice at perinatal ages and are reduced only in 
adult Cdk2
−/− mice. Adult Cdk2
−/− SVZ cells in culture 
display decreased self-renewal capacity and enhanced 
differentiation. Compensatory mechanisms in perinatal 
Cdk2
−/− SVZ cells, which persist until postnatal day 15, 
involve increased Cdk4 expression that results in retino-
blastoma protein inactivation. A subsequent decline in 
Cdk4 activity to wild-type levels in postnatal day 28 
Cdk2
−/− cells coincides with lower NG2
+ proliferation 
and self-renewal capacity similar to adult levels. Cdk4 
  silencing in perinatal Cdk2
−/− SVZ cells abolishes Cdk4 
up-regulation and reduces cell proliferation and self-
renewal to adult levels. Conversely, Cdk4 overexpression 
in adult SVZ cells restores proliferative capacity to wild-
type levels. Thus, although Cdk2 is functionally redundant 
in   perinatal SVZ, it is important for adult progenitor cell 
proliferation and self-renewal through age-dependent 
regulation of Cdk4.
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In the anterior SVZ (ASVZ), neural progenitors express-
ing the chondroitin sulfate proteoglycan NG2 (NG2
+ progeni-
tors) represent a principal population of proliferating cells 
(Dawson et al., 2000; Aguirre et al., 2004). NG2
+ cells are pres-
ent in the SVZ from birth until adulthood and display cellular 
properties of transient-amplifying (type C) cells, generating 
γ-aminobutyric acid–ergic interneurons and oligodendrocytes in 
the olfactory bulb (Aguirre and Gallo, 2004; Menn et al., 2006). 
Previous studies have demonstrated that the Cdk2–cyclin E 
complex plays an important role in regulating NG2
+ progenitor 
cell cycle in culture and that Cdk2 expression is down-regulated 
in adult progenitors (Ghiani and Gallo, 2001; Belachew et al., 
2002). However, it is still unknown whether Cdk2 is function-
ally required for NG2
+ progenitor proliferation in vivo and 
whether this requirement changes during postnatal development 
of the SVZ. Furthermore, a previous analysis also revealed 
higher levels of the Cdk4/6–cyclin D complex in dividing versus 
quiescent NG2
+ progenitors, which suggests a possible involve-
ment of this kinase in maintaining cell proliferation (Ghiani and 
Gallo, 2001).
To assess the role of intrinsic cell cycle regulators in pro-
genitor proliferation during developmental and adult neuro- and 
gliogenesis, we analyzed the NG2
+ progenitor cell population 
in Cdk2
−/− mice. Our results demonstrate that the lack of Cdk2 
signifi  cantly affects progenitor cell proliferation in neurogenic 
regions only after reaching a juvenile stage of postnatal develop-
ment, which results in a severe reduction of NG2
+ cell quantity 
and proliferation. We also provide direct evidence that the de-
fect in NG2
+ progenitor cell proliferation observed in the adult 
SVZ of the Cdk2
−/− mouse is compensated by Cdk4 at earlier 
developmental stages. Finally, we show that Cdk2 also plays an 
important role in controlling oligodendrocyte and neuron lin-
eage commitment in the adult brain.
Results
Loss of Cdk2 causes a decrease in cell 
proliferation in neurogenic regions of the 
adult brain
We investigated the role of Cdk2 on SVZ neural progenitor cell 
proliferation by comparing Cdk2
−/− and wild-type mice. We fi  rst 
analyzed two developmental stages, one corresponding to the 
peak of NG2
+ progenitor proliferation (postnatal day 8 [P8]) and 
the other corresponding to a proliferative plateau (P90; Belachew 
et al., 2002; Aguirre et al., 2004). We used anti-BrdU staining to 
identify cells progressing through S phase and anti-Ki67 stain-
ing for cells in G1, S, M, or G2 phase. We analyzed neurogenic 
areas of the brain where stem cells and neural progenitors pro-
liferate and differentiate, including the ASVZ, the lateral SVZ 
(LSVZ; Fig. 1 A, left), and the path of cell migration along the 
rostral migratory stream (RMS) toward the olfactory bulb (Fig. 1 A, 
right). At P8, the loss of Cdk2 did not affect the percentage of 
BrdU
+ and Ki67
+ cells in all brain regions examined (Fig. 1 B). 
Conversely, in P90 brains, the percentage of cells positive for 
these cell cycle markers was signifi  cantly decreased in the ASVZ, 
LSVZ, and RMS of the Cdk2
−/− mouse as compared with the 
wild type (Figs. 1 C and S1, available at http://www.jcb.org/cgi/
content/full/jcb.200702031/DC1).
Loss of Cdk2 selectively impairs NG2-
expressing progenitor cell proliferation 
in the adult SVZ
In the adult SVZ, slowly dividing (type B) stem cells expressing 
glial fi  brillary acidic protein (GFAP) and vimentin give rise to 
highly proliferative transient-amplifying (type C) cells, which 
express Mash1 and Dlx2. These cells differentiate into neuro-
blast (type A) cells characterized by class III β-tubulin (Tuj1), a 
polysialylated form of neural cell adhesion molecule, or double-
cortin (Dcx) expression (Doetsch et al., 2002). To identify cell 
populations of the neurogenic niche directly affected by loss 
of the Cdk2 gene, we performed immunohistochemical analysis 
using antibodies against GFAP and the proteoglycan NG2 in 
combination with a variety of other cellular markers. The per-
centage of GFAP-expressing cells was higher in the LSVZ than in 
the ASVZ in both P8 and 90 brains of wild-type and Cdk2
−/− mice 
(Fig. S2, J1 and 3, available at http://www.jcb.org/cgi/content/
full/jcb.200702031/DC1). This fi  nding was consistent with pre-
vious analyses demonstrating that most stem cells are born 
in the LSVZ, where their self-renewal is supported by endothe-
lial cells (Shen et al., 2004). Loss of Cdk2 had no effect on the 
proliferative potential of GFAP
+ cells in the ASVZ and LSVZ 
of P8 or 90 mice   (Fig. S2, J2 and 4), which suggests that Cdk2 
Figure 1.  Loss of Cdk2 causes a reduction of cell proliferation in the SVZ 
and RMS of the adult brain. (A) Schematic drawings of coronal (left) and 
sagittal (right) planes of sections showing neurogenic areas of the brain. 
Proliferating cells were labeled with anti-BrdU and -Ki67 in the ASVZ (left), 
LSVZ (left), and RMS (right). (B and C) Percentages of proliferating cells 
were calculated based on the total number of DAPI cells. At P8, the per-
centages of BrdU
+ (left) or Ki67
+ (right) cells in the ASVZ, LSVZ, and RMS 
of the Cdk2
−/− mouse were similar to the wild type. At P90, a signiﬁ  cant 
decrease in BrdU
+ (left) and Ki67
+ (right) cells was observed in all regions 
of the Cdk2
−/− mouse. Results are expressed as means ± the SEM. *, P < 
0.05; results were analyzed by a t test (six to eight hemispheres were used 
for analysis for each age and marker).CDK2 CONTROLS ADULT SVZ PROGENITOR SELF-RENEWAL • JABLONSKA ET AL. 1233
activity is either nonessential for slowly dividing type B cells or 
can be compensated by other Cdks at both ages.
Because anti-GFAP antibodies also label astrocytes, we 
used nestin as a marker of undifferentiated cells to identify the 
adult stem cell population. The percentage of GFAP
+–nestin
+ 
cells was higher in P90 than in P8 SVZ, confi  rming that this is a 
major cell population in the adult SVZ (Fig. S3, I and J, available 
at http://www.jcb.org/cgi/content/full/jcb.200702031/DC1). 
  Interestingly, in both P8 and 90 brains, no signifi  cant changes 
were found in the percentage of GFAP
+–nestin
+ neural stem 
cells in all structures (Fig. S3). Conversely, a signifi  cant effect 
on NG2
+ progenitor cell proliferation was observed in the absence 
of Cdk2 (Fig. 2). At P90, NG2
+ proliferation was signifi  cantly 
reduced in neurogenic regions of the Cdk2
−/− brain (Fig. 2 D), 
whereas no changes were observed at P8 (Fig. 2 D).
Consistent with these fi  ndings, we also observed a signifi  -
cant decrease of NG2
+ cell density in the SVZ and RMS of the 
Cdk2
−/− mouse. NG2
+ cells were counted in the ASVZ, LSVZ, 
and RMS using confocal z stack images. In the SVZ and RMS, 
the typical morphology of migratory NG2
+ cells was character-
ized by an oval cell body and one or two long leading processes 
(Fig. 3, A1–3). However, in the striatum, NG2
+ cells displayed 
a postmigratory morphology with a larger and more rounded 
cell body and many branched processes (Fig. 3, A1–3). Two 
independent counting methods (volume density and cell number 
relative to the total number of cells) demonstrated that in the 
Figure 2.  Decreased proliferation of NG2-
expressing progenitors in neurogenic areas of 
the adult Cdk2
−/− mouse. (A–C) Tricolored im-
ages show NG2
+ progenitor cells (green) in 
the ASVZ, LSVZ, and RMS (LV, lateral ventricle; 
ctx, cortex; str, striatum) on sagittal sections 
obtained from wild-type (A1–3) and Cdk2
−/− 
(B1–3) mice stained with anti-BrdU (red) and 
DAPI (blue). Arrows indicate proliferating 
NG2
+ progenitors. White dotted lines deline-
ate the ASVZ (A1 and B1), LSVZ (A2 and B2), 
and RMS (A3 and B3). (C1–4) Cdk2
−/− 
mouse. Magniﬁ  ed view of NG2
+ progenitors 
(C2, anti-NG2) labeled with anti-BrdU (C1) 
and DAPI (C3). Merged image is shown in 
C4. (D) Percentages of double-labeled cells. 
At P8, no differences in the percentage of 
NG2
+–BrdU
+ or NG2
+–Ki67
+ cells were ob-
served in the ASVZ, LSVZ, and RMS between 
wild-type and Cdk2
−/− mice (D, top left and 
right), whereas at P90 there was a signiﬁ  cant 
reduction in the percentage of proliferating 
NG2
+ cells in the Cdk2
−/− brain (D, bottom 
left and right). Results are expressed as means ± 
the SEM. *, P < 0.05; results were analyzed 
by a t test (six to eight hemispheres were taken 
for analysis for each age and marker). Bars: 
(A and B) 50 μm; (C) 12 μm.JCB • VOLUME 179 • NUMBER 6 • 2007  1234
adult Cdk2
−/− neurogenic brain areas, there was a signifi  cant 
reduction in the density of NG2
+ progenitors (Fig. 3 B, bottom). 
Consistent with the cell proliferation results, no differences in 
cell density were observed between Cdk2
−/− and wild-type 
brains at P8 (Fig. 3 B, top). Consistent with the cell proliferation 
and density data, counts of the total number of NG2
+ cells in the 
SVZ also showed a signifi  cant decrease at P90 (wild type, 425 ± 
55 cells; Cdk2
−/−, 290 ± 36 cells; n = 4 brains; P < 0.04, re-
sults were analyzed with a t test) but not at P8 (wild type, 409 ± 
50 cells; Cdk2
−/−, 400 ± 51 cells; n = 3 brains).
Finally, we investigated the contribution of apoptosis to the 
reduction of progenitor cell proliferation in Cdk2
−/− mouse brains. 
Caspase-3
+ apoptotic cells were quantifi  ed and no differences were 
observed in cell death between Cdk2
−/− and wild-type mice at P8 or 
90 (Fig. S4, A–F, available at http://www.jcb.org/cgi/content/full/
jcb.200702031/DC1). Similarly, no differences were observed in 
the percentage of TUNEL
+ cells at both ages (Fig. S4, G and H).
Collectively, these data indicate that the lack of Cdk2 has 
important cell- and developmental stage–specifi  c effects in the 
adult SVZ because (a) it selectively decreases NG2
+ cell prolif-
eration without altering GFAP
+ stem cell production and (b) it 
only affects NG2
+ cells in the adult brain.
Loss of Cdk2 promotes lineage commitment 
of NG2-expressing progenitors in the 
adult brain
Double immunostaining of NG2
+ cells with anti-nestin anti-
bodies indicated that the population of undifferentiated NG2
+–
nestin
+ progenitors decreased by  48, 37, and 32%, respectively, 
in the ASVZ, LSVZ, and RMS of adult Cdk2
−/− mice (Fig. 4 D, 
bottom). In contrast, no changes in the percentage of NG2
+–
nestin
+ cells were observed at P8 (Fig. 4 D, top).
We have previously demonstrated that postnatal SVZ NG2
+ 
progenitors acquire expression of the committed oligodendrocyte 
and neuronal progenitor markers Nkx2.2 and Dcx, respectively 
(Aguirre and Gallo, 2004). At P90, we observed an increase in 
the percentage of NG2
+–Nkx2.2
+ and NG2
+–Dcx
+ cells in the 
ASVZ, LSVZ, and RMS of the Cdk2
−/− mouse (P < 0.05, t test; 
Fig. 4, E and F, bottom). In contrast, NG2
+ cell differentiation 
was not modifi  ed by Cdk2 loss at P8 (Fig. 4, E and F, top). 
No NG2
+–GFAP
+ cells were detected in the brain areas ana-
lyzed at P8 or 90 (unpublished data).
In conclusion, these fi  ndings indicate that Cdk2 does not 
uniformly regulate NG2
+ cell differentiation throughout onto-
genic development because Cdk2 loss promotes oligodendrocytic 
Figure 3.  Decreased density of NG2-expressing progenitors in neurogenic areas of the adult Cdk2
−/− mouse. (A) NG2
+ progenitors present in the ASVZ, 
LSVZ, and RMS display a migratory cellular morphology as opposed to those in the striatum. White dotted lines delineate the ASVZ (A1), LSVZ (A2), and 
RMS (A3). Bar, 100 μm. (B) NG2
+ progenitor number was estimated as total number of cells per 100 μm
3 throughout the entire depth of the sections (left) 
and as a percentage of total DAPI-labeled cells (right) using confocal z-stack analysis. At P8, no changes in the density and proportion of NG2
+ progenitors 
between the wild type and Cdk2
−/− were observed, whereas a signiﬁ  cant reduction of NG2
+ cell density and proportion was observed at P90 in the 
ASVZ, LSVZ, and RMS of the Cdk2
−/− mouse. Results are expressed as means ± the SEM. *, P < 0.05; results were analyzed by a t test (six to eight hemi-
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and neuronal commitment at P90 but not P8. Consistent with 
these data, Cdk2 loss causes a signifi  cant decrease in the pool of 
undifferentiated NG2
+–nestin
+ cells only in the adult SVZ.
Loss of Cdk2 function causes a decrease 
in self-renewal potential and an increase 
in the differentiation of adult neural 
progenitor cells
SVZ NG2
+ cells are able to form neurospheres (Aguirre et al., 
2004; Aguirre and Gallo, 2004) and differentiate into neurons, 
oligodendrocytes, and astrocytes in culture (Belachew et al., 2002). 
To correlate the selective decrease of adult NG2
+ cell prolifera-
tion in Cdk2
−/− SVZ in vivo with a functional in vitro assess-
ment of their self-renewal potential, we performed neurosphere 
formation assays using Cdk2
−/− and wild-type SVZ cells at P8 
and 90. In these experiments and in the experiments shown in 
Figs. 5–10, we used total SVZ cells or tissue for our biochemi-
cal and cellular analysis because of the limitations imposed by 
the system (i.e., number of cells in the SVZ) and the use of 
Cdk2
−/− mice (the limited number of Cdk2
−/− mice per litter). 
Furthermore, rapidly dividing NG2
+ progenitor cells represent 
the largest progenitor cell population in the postnatal and adult 
Figure 4.  Cdk2 loss promotes lineage speciﬁ  cation of adult NG2
+ progenitor cells. (A–C) All micrographs were taken from the ASVZ in wild-type and 
Cdk2
−/− mice at P90. Immunostaining shows undifferentiated NG2
+–nestin
+ progenitors (A1 and 2 and higher magniﬁ  cation in A3–5), Nkx2.2
+ 
  oligodendrocyte progenitors (B1 and 2 and higher magniﬁ  cation in B3–6), and Dcx
+ neuroblasts (C1 and 2 and higher magniﬁ  cation in C3–5). White dotted 
lines delineate the ASVZ. (D–F) Histograms represent percentages of NG2
+–nestin
+, NG2
+–Nkx2.2
+, and NG2
+–Dcx
+ cells calculated from the number of 
total NG2
+ cells. At P8, no changes between wild-type and Cdk2
−/− mice were observed in the number of NG2
+ undifferentiated cells (D, top) as well as 
oligodendrocyte progenitors (E, top) and neuroblasts (F, top) within the ASVZ, LSVZ, and RMS. In the P90 Cdk2
−/− brains, the pool of undifferentiated 
NG2
+ progenitors was partially depleted in the ASVZ, LSVZ, and RMS (D, bottom), whereas a signiﬁ  cant increase was observed in the percentage of com-
mitted Nkx2.2
+ oligodendrocyte progenitors (E, bottom) and Dcx
+ postmitotic neuroblasts (F, bottom). Data are expressed as means ± the SEM. *, P < 
0.05; results were analyzed by a t test (six to eight hemispheres were taken for analysis for each age and marker). Bars: (A1 and 2, B1 and 2, and C1 
and 2) 50 μm; (A3–5, B3–6, and C3–5) 15 μm.JCB • VOLUME 179 • NUMBER 6 • 2007  1236
SVZ (Aguirre et al., 2004; Aguirre and Gallo, 2004), and GFAP
+ 
type B cells are not affected by Cdk2 loss; therefore, our fi  nd-
ings in total SVZ cells relate to the NG2
+ cell population.
The number of neurospheres obtained from Cdk2
−/− and 
wild-type SVZ cells was determined after three successive pas-
sages during a total time window of 21 d in vitro. At P8, the num-
ber of growing neurospheres per 10,000 seeded cells was similar 
in wild-type and Cdk2
−/− mice during all passages (mean num-
ber of cells ± the SEM; Fig. 5 C, left), which indicates that 
SVZ cell self-renewal potential was not modifi  ed by Cdk2 loss. 
The fi  rst passage of P90 cultures showed a much lower number 
of neurospheres as compared with P8. This was likely caused by 
the lower percentage of neurosphere-forming cells in the adult 
SVZ as compared with earlier developmental stages. In P90 
cells, the number of neurospheres greatly increased between the 
fi  rst and second passages (Fig. 5 C, right), most likely because 
of the selective survival of highly proliferative cells after the 
fi  rst passage.
Consistent with the data obtained in situ, loss of Cdk2 
caused a signifi  cant decrease in neurosphere formation in P90 
cultures (mean number of cells ± the SEM; Fig. 5 C, right), which 
demonstrates that adult SVZ cell self-renewal potential was 
signifi  cantly impaired by the loss of Cdk2. Neurosphere size 
analysis indicated a slight reduction in the number of adult 
Cdk2
−/− spheres within the range of 100–300 μm in diameter and 
a signifi  cant decrease in the number of spheres within the 300–
600-μm range and >600 μm (percentage of decrease: 0–100 μm, 
6%; 100–150 μm, 23%; 150–300 μm, 95%; 300–600 μm, 97%; 
Fig. 5 D, right). Conversely, in P8 cultures, the size of neuro-
spheres was not affected by the loss of Cdk2 (Fig. 5 D, left). These 
results were confi  rmed in neurospheres obtained from NG2
+ cells 
that were FACS purifi  ed from P8 and 90 SVZ tissues (Fig. 5 E).
We investigated whether the absence of Cdk2 also regu-
lates the multilineage potential of neurospheres and performed 
clonal analysis on neurospheres differentiated in culture for 7 d 
(Fig. 6). Among the progeny of Cdk2
−/− neurospheres obtained 
from P90 mice, we observed a signifi  cant overall increase of 
  differentiated cell phenotypes, including microtubule-associated 
protein 2
+ (MAP2
+) neurons, galactocerebroside
+ (GalC
+) 
 oligodendrocytes,  and  GFAP
+ astrocytes (Fig. 6 G). Conversely, 
similar percentages of all differentiated cell types were found in 
the second and third passages of P8 Cdk2
−/− and wild-type cul-
tures (Fig. 6 G). Semiquantitative RT-PCR analysis demonstrated 
an increase in oligodendrocyte transcription factor 1 (Olig1), 
Figure 5.  The absence of Cdk2 selectively impairs neurosphere 
formation in adult Cdk2
−/−cultures. (A and B) SVZ neurospheres 
were obtained from single cell suspensions from wild-type and 
Cdk2
−/− mice at P8 (A1 and 2) and P90 (B1 and 2). Bar, 500 μm. 
(C) To assess self-renewal potential, neurosphere numbers were 
counted after the ﬁ  rst, second, and third passage, respectively. 
No changes in the number of growing neurospheres were ob-
served in P8 cultures (C, left), whereas a signiﬁ  cant decrease of 
neurosphere growth was observed in P90 Cdk2
−/− cultures after 
each passage (C, right). Data were obtained from three independ-
ent experiments and are expressed as means ± the SEM. *, P < 
0.05; results were analyzed by a t test. (D) For size analysis, only 
neurospheres within the range of 100–600 μm were counted. 
The number of neurospheres bigger than 300 μm was signiﬁ  cantly 
reduced in P90 Cdk2
−/− cultures (D, right) but was unaffected in 
P8 Cdk2
−/− cultures (D, left). *, P < 0.05, results were analyzed 
by a t test. (E) Neurosphere formation from FACS-puriﬁ  ed NG2
+ 
SVZ cells (wild type and Cdk2
−/−) at P8 and 90. (E, left) At P8, 
no differences were found in the number of NG2
+ cell–derived 
neurospheres between Cdk2
−/− and wild-type cells. Conversely, 
a signiﬁ  cant decrease in the number of neurospheres was found 
in FACS-sorted NG2
+ Cdk2
−/− cells at P90 as compared with the 
wild type. Data were obtained from three independent experi-
ments and are expressed as a ratio between Cdk2
−/− and wild-
type NG2
+ cell–derived neurospheres. All data are expressed as 
means ± the SEM. *, P < 0.005; results were analyzed by a 
t test. (E, right) Images of wild-type and Cdk2
−/− neurospheres 
from FACS-sorted P90 NG2
+ cells. Bar, 250 μm.CDK2 CONTROLS ADULT SVZ PROGENITOR SELF-RENEWAL • JABLONSKA ET AL. 1237
GFAP, and Tubb3 gene expression in P90 but not P8 Cdk2
−/− 
neurospheres as compared with wild-type cells (Fig. 6 H). 
  Altogether, these in vitro data confi  rmed our results in situ and 
strongly support the idea that, in the adult brain, Cdk2 plays a 
critical role not only in SVZ cell proliferation but also in neural 
progenitor self-renewal potential and differentiation.
Cdk4 transiently compensates for Cdk2 
loss during early postnatal development 
of the SVZ
Cell cycle progression is associated with the activity of four 
Cdks (Cdc2/Cdk1 and Cdk2, 4, and 6). Knockout mouse mod-
els have provided important insight into the functional inter-
play between these Cdks (Berthet et al., 2006). Most of these 
single knockout models do not exhibit major cell cycle defects, 
which reveals redundancies and suggests that a single Cdk 
might be suffi  cient to drive the cell cycle at least during embry-
onic development.
To gain further insight into the molecular mechanisms under-
lying the involvement of Cdk2 in SVZ cell proliferation, we 
fi  rst analyzed expression of (a) Cdc2/Cdk1, Cdk4, and Cdk6; 
(b) their activating partners cyclin D and E; and (c) the Cdk 
 inhibitors  p16
Ink4D, p53, p21
Cip1, and p27
Kip1 in wild-type and 
Cdk2
−/− SVZ protein extracts from P8 and 90 mice. At P8, 
Western blot analysis showed strong up-regulation of Cdk4 pro-
tein levels and kinase activity and a nonsignifi  cant increase of 
cyclin D and Cdk6 expression in Cdk2
−/− SVZ as compared 
with the wild type (Fig. 7, B and C; and Fig. S5, available at 
http://www.jcb.org/cgi/content/full/jcb.200702031/DC1). At P8, 
a 2.2-fold increase in Cdk4 activity was observed (Fig. S5).
Figure 6.  Cell differentiation of SVZ progeni-
tors is enhanced by loss of Cdk2. (A–F) Cells 
plated from SVZ neurospheres obtained from 
wild-type (A1 and 2 and D1 and 2) and 
Cdk2
−/− (B1 and 2 and E1 and 2) mice differ-
entiated into oligodendrocytes, astrocytes, and 
neurons as stained with antibodies against 
GalC, GFAP, and MAP2, respectively. Higher 
magniﬁ  cation images show the individual cell 
types at P8 (C1–9) and P90 (F1–9). (G) Com-
parable percentages of neurons, astrocytes, 
and oligodendrocytes were obtained from 
Cdk2
−/− and wild-type neurospheres at P8 after 
second and third passages, but signiﬁ  cantly 
higher percentages of all differentiated cell 
phenotypes were found in Cdk2
−/− cells at 
P90. Data are expressed as means ± the SEM. 
*, P < 0.05; results were analyzed using a 
t test. (H) Semiquantitative RT-PCR analysis con-
ﬁ  rmed immunolabeling of cells and showed in-
creased levels of oligodendrocyte transcription 
factor 1 (Olig1), GFAP, and Tubb3 gene ex-
pression in P90 Cdk2
−/− cells. At P8, no differ-
ences in gene expression were observed. Actin 
and EGFR were used as internal positive controls. 
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Conversely, at P90, the levels of all Cdks analyzed and 
Cdk4 activity were similar in Cdk2
−/− and wild-type SVZ tis-
sue extracts but an elevation of p21
Cip1 expression was detected 
in Cdk2
−/− SVZ (Fig. 7, B and C; and Fig. S5). At this age, a 
nonsignifi  cant decrease in cyclin D and a nonsignifi  cant in-
crease in cyclin E were also observed (Fig. 7 B). These fi  ndings 
suggest that the elevation of Cdk4 levels and activity observed 
at P8 might compensate for the loss of Cdk2 and contribute to 
the maintenance of similar proliferation in Cdk2
−/− and wild-
type SVZ cells.
A developmental time course revealed that the loss of Cdk4 
overexpression in the Cdk2
−/− SVZ occurred between P15 and 
28 (Fig. 8, A and B) in parallel with a decline of Cdk4 kinase 
activity (Fig. 8 C). Finally, we also assessed by immunoprecipi-
tation the ability of E2F-4 transcription factors to associate with the 
Cdk4-activated pRb family member p107 (Fig. 8 D; Beijersbergen 
et al., 1995). Only the unphosphorylated form of p107 can bind 
E2F-4 (Beijersbergen et al., 1995); therefore, the analysis of 
p107–E2F-4 interaction represents an indirect assessment of a 
Cdk4-activated pathway (Fig. 8 D). A direct comparison be-
tween Cdk2
−/− and the wild type at P8 and 15 indicated that the 
levels of p107 associated with E2F-4 were lower in Cdk2
−/− 
than in wild-type SVZ cells, suggesting that Cdk4-mediated 
phosphorylation of p107 in the Cdk2
−/− SVZ at this develop-
mental stage was increased (Figs. 8 D and S5). Conversely, p107 
was found to be associated with E2F-4 to a similar extent in 
Cdk2
−/− and wild-type SVZ cells at P28 (Figs. 8 D and S5).
We also wanted to defi  ne whether the developmental de-
cline of Cdk4 overexpression that occurred between P15 and 28 
in the Cdk2
−/− SVZ (Fig. 8) correlated with a decrease in NG2
+ 
cell proliferation and neurosphere formation. At P15, the total 
number of BrdU
+ cells (Fig. 9 A, left) and NG2
+ cell proliferation 
(Fig. 9 B, left) in the ASVZ, LSVZ, and RMS, as well as neuro-
sphere formation (number and size; Fig. 9, C1 and 2, E [left], 
and F [left]) were undistinguishable in Cdk2
−/− and wild-type 
cells. Conversely, at P28, when Cdk4 expression and activity 
were similar in the Cdk2
−/− and wild-type SVZ (Fig. 8), total 
cell and NG2
+ cell proliferation and neurosphere formation 
were signifi  cantly decreased in Cdk2
−/− cells (Fig. 9, A and B 
and D–F, right).
Altogether, these results point to a possible compensatory 
role of the Cdk4 pathway, which might be involved in maintain-
ing the appropriate pool of SVZ NG2
+ progenitors in the ab-
sence of Cdk2 during earlier stages of postnatal development.
Cdk4 loss- and gain-of-function modiﬁ  es 
perinatal and adult Cdk2
−/− SVZ progenitor 
cell proliferation and self-renewal, 
respectively
We predicted that, if Cdk4 compensated for the loss of Cdk2 in 
P8 SVZ cells, down-regulation of its expression in Cdk2
−/− 
SVZ cells at this developmental stage would cause a decrease in 
their proliferation. Conversely, Cdk4 overexpression in P90 
Cdk2
−/− SVZ cells would enhance their proliferative potential.
Loss of function. We performed siRNA-mediated 
Cdk4 knockdown in P8 SVZ cultures from wild-type and 
Cdk2
−/− mice. Transfection with Cdk4 siRNA signifi  cantly 
decreased Cdk4 expression levels in both cell types (53% in 
wild-type and 47% in Cdk2
−/− cells; Fig. 10 A). In the same 
set of experiments, the levels of Cdk4 proteins were un-
affected by the scrambled siRNA (Fig. 10 A). Furthermore, as 
expected, cell transfection with Cdk2 siRNA decreased Cdk2 
expression in wild-type cells but had no effect in Cdk2
−/− cells 
(Fig. 10 A).
Figure 7.  Expression of cell cycle–related 
proteins is modiﬁ   ed in the Cdk2
−/− SVZ. 
(A) Schematic drawing of the major compo-
nents of the Cdk2 and Cdk4/6 pathways. 
(B) Western blot analysis shows that at P8, 
Cdk4, Cdk6, and cyclin D protein levels were 
elevated in Cdk2
−/− SVZ as compared with the 
wild type. At P90, only p21
Cip1 and cyclin E 
expression were higher in Cdk2
−/− than in 
wild-type SVZ. Actin was used as a loading 
control. (C) At P8, signiﬁ  cant differences were 
found only for Cdk4 expression, whereas differ-
ences in Cdk6 and cyclin D were not signiﬁ  cant. 
At P90, the increase in p21
Cip1 expression was 
signiﬁ  cant. Data are expressed as means ± 
the SEM. *, P < 0.001; results were analyzed 
by a t test. Each histogram was obtained from 
the independent Western blot analysis of three 
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To study the functional effect of Cdk4 and 2 siRNA on 
neurosphere formation, we plated transfected SVZ cells from 
wild-type and Cdk2
−/− brains and cultured them in a medium 
containing mitogenic factors. After 7 d, neurospheres were 
  generated in both scrambled control and Cdk4 and 2 siRNA– 
transfected cells (Fig. 10 B). Treatment with scrambled Cdk4 and 2 
siRNA did not signifi  cantly affect neurosphere formation in 
Cdk2
−/− cultures as compared with the wild type (Fig. 10 B). 
Conversely, transfection of Cdk2
−/− cultures with Cdk4 siRNA 
caused a 58% reduction in the number of neurospheres as com-
pared with scrambled control (Fig. 10 B). Transfection of wild-
type cultures with Cdk2 siRNA caused a 40% reduction in 
neurosphere quantity (Fig. 10 B). In wild-type and in Cdk2
−/− 
cultures, the number of neurospheres was not affected by Cdk4 
or 2 silencing, respectively (Fig. 10 B). This strongly suggests 
that Cdk4 mostly has a compensatory role for Cdk2 function in 
early postnatal development.
Cell proliferation analysis after Cdk4 siRNA transfection 
was consistent with the neurosphere formation assays. Percent-
ages of BrdU
+ cells in wild-type and Cdk2
−/− neurospheres 
were unaffected after transfection with scrambled Cdk4 and 2 
siRNA sequences, respectively (Fig. 10 C). Conversely, Cdk4 
siRNA treatment signifi  cantly decreased cell proliferation in 
Cdk2
−/− cultures, as shown by the 70% reduction in BrdU
+ cells 
(Fig. 10 C). In wild-type neurospheres, cell proliferation was 
only slightly decreased by  15% (Fig. 10 C), which further sup-
ports the idea that SVZ cell proliferation also depends on Cdk4 
activity. Finally, as expected, Cdk2 siRNA treatment signifi  -
cantly and selectively decreased cell proliferation in wild-type 
neurospheres but had no effect in Cdk2
−/− cells (Fig. 10 C).
Gain of function. We overexpressed Cdk4 in P90 
Cdk2
−/− cells to determine whether increased activity of this 
kinase would enhance cell proliferation and renewal. pCMV-
Cdk4 transfection greatly increased Cdk4 expression in both 
wild-type and Cdk2
−/− SVZ cells as compared with the empty 
vector (Fig. 10 D). Cdk4 overexpression completely reversed 
the phenotype in adult Cdk2
−/− SVZ cells as demonstrated by 
neurosphere formation (Fig. 10 E) and cell proliferation (Fig. 10 F) 
assays. In both sets of experiments, the behavior of Cdk2
−/− cells 
was indistinguishable from their wild-type counterparts, which 
indicates that restoring Cdk4 expression in P90 Cdk2
−/− SVZ 
cells is suffi  cient to compensate for Cdk2 loss.
Altogether, these loss- and gain-of-function data confi  rm 
that Cdk4 is required for maintaining an appropriate pool of divid-
ing SVZ cells in culture and that the endogenous up-regulation 
of Cdk4 that occurs in SVZ progenitors at the early postnatal 
stage can functionally compensate for the loss of Cdk2.
Discussion
The identifi  cation of extrinsic and intrinsic factors governing 
progenitor cell proliferation and differentiation in neurogenic 
regions of the postnatal brain is crucial to elucidate fundamental 
mechanisms of postnatal neuro- and gliogenesis. Although our 
knowledge of extracellular signals that regulate neural progeni-
tor cell division is quite extensive, the specifi  c role of intrinsic 
regulators is less well defi  ned. In this paper, we took advantage 
of a viable Cdk2
−/− mouse mutant to investigate the functional 
role of cell cycle regulators in neural progenitor proliferation 
and differentiation in neurogenic regions of the postnatal brain. 
Our fi  ndings point to Cdk2 as a cell-intrinsic determinant of 
progenitor cell proliferation and differentiation and indicate that 
Cdk2 plays a nonredundant role in maintaining the pool of 
dividing and undifferentiated progenitor cells in the SVZ of the 
adult brain.
Age- and cell type–speciﬁ  c function of Cdk2 
in the SVZ
Previous studies identifi  ed NG2-expressing progenitors of the 
postnatal SVZ as the transient-amplifying type C cells based on 
their antigenic and cellular properties as well as their lineage po-
tential (Aguirre et al., 2004; Parras et al., 2004; Menn et al., 2006). 
The NG2-expressing cell population is highly proliferative, can 
form neurospheres in culture, and can generate both neurons and 
Figure 8.  Up-regulation of Cdk4 expression 
and activity in the Cdk2
−/− SVZ decline to adult 
levels between P15 and 28. (A and B) SVZ tissue 
lysates were immunoblotted with anti-Cdk4 anti-
bodies and band intensities were measured and 
normalized to actin. Note that the increase in 
Cdk4 expression in Cdk2
−/− tissue is develop-
mentally regulated and was lost at P28. Each 
histogram was obtained from an independent 
Western blot analysis of three to four SVZs. *, P < 
0.05; results were analyzed by a t test. (C) Cdk4 
activity was up-regulated in Cdk2
−/− SVZ at 
P15 but not P28. Cdk4 activity was measured 
using glutathione S-transferase Rb protein as a 
substrate. (D) At P15, E2F4-bound p107 was 
lower in Cdk2
−/− than in wild-type SVZ, which 
indicates enhanced activation of the Cdk4 path-
way. Conversely, at P28, E2F4-bound p107 
was similar in Cdk2
−/− and wild-type SVZ. E2F4-
bound p107 was coimmunoprecipitated with 
anti-E2F4 antibodies and probed on Western 
blot with anti-p107 antibodies. Importantly, 
p107 expression levels did not change at either 
age in Cdk2
−/− versus wild-type SVZ as shown 
by Western blot with anti-p107 antibodies.JCB • VOLUME 179 • NUMBER 6 • 2007  1240
oligodendrocytes (Aguirre et al., 2004; Aguirre and Gallo, 2004). 
In this paper, we show that NG2
+ cell proliferation is selectively 
impaired in the adult SVZ of mice lacking Cdk2. Importantly, 
loss of Cdk2 did not affect proliferation of slowly dividing 
GFAP
+–nestin
+ stem cells, indicating that intrinsic cell cycle 
regulators play distinct roles in different cell populations of the 
adult SVZ. Analysis in cultures obtained from adult SVZ cells 
is consistent with the in vivo fi  ndings, as a signifi  cant decrease 
in the formation of neurospheres was also observed in Cdk2
−/− 
cells. Our results place Cdk2 among previously described cell 
type–specifi  c modulators that regulate SVZ progenitor prolifer-
ation, such as p27
Kip1 or p19
INK4d (Casaccia-Bonnefi  l et al., 1999; 
Coskun and Luskin, 2001; Doetsch et al., 2002; Li et al., 2006). 
Moreover, it appears that Cdk2 might play a prominent role in 
adult neural progenitors because loss of this kinase did not af-
fect proliferation of embryonic fi  broblasts or human colon can-
cer cell lines in culture (Berthet et al., 2003; Ortega et al., 2003; 
Tetsu and McCormick, 2003).
The specifi  c mechanism by which Cdk2 participates in the 
regulation of NG2
+ progenitor cell proliferation is still un-
defi  ned. Deregulation of Cdk2 activity is often associated with 
changes in the rate of entry into S phase (Duronio et al., 1996; 
Figure 9.  Reduction of Cdk4 levels in Cdk2
−/− 
SVZ during postnatal development correlates with 
a decrease in neural progenitor cell proliferation 
and self-renewal. (A) BrdU immunolabeling shows 
that proliferation of total SVZ cells is similar in 
Cdk2
−/− and wild-type brains at P15 (A, left), 
whereas cell proliferation is signiﬁ  cantly decreased 
in the Cdk2
−/− SVZ at P28 (A, right). Similar re-
sults were obtained by analyzing NG2
+ progenitors 
at P15 (B, left) and P28 (B, right). Data repre-
sent BrdU
+ cells as percentages of total DAPI-
  labeled cells (A1 and 2) or total NG2
+ cells (B1 
and 2). Data were obtained from at least three 
separate brains. *, P < 0.001; results were ana-
lyzed by a t test. (C–E) Neurosphere numbers 
were counted after the ﬁ  rst, second, and third pas-
sage, respectively. No changes in the number of 
neurospheres were observed in P15 cultures (C1 
and 2 and E, left), whereas a signiﬁ  cant decreased 
was observed in P28 Cdk2
−/− cultures (D1 and 2 
and E, right). Bar, 500 μm. Data were obtained 
from three independent experiments. (F) For size 
analysis, only neurospheres within the range of 
100–600 μm were counted. The number of neuro-
spheres bigger than 300 μm was signiﬁ  cantly re-
duced in P28 Cdk2
−/− cultures but was unaffected 
in P15 Cdk2
−/− cultures. All data are expressed 
as means ± the SEM. *, P < 0.05; results were 
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Hua et al., 1997; Krude et al., 1997). Previous analysis demon-
strated that the absence of Cdk2 signifi  cantly delays the entry of 
synchronized fi  broblasts into S phase (Berthet et al., 2003); 
therefore, it is likely that Cdk2 might also be involved in the reg-
ulation of S phase entry in NG2
+ progenitors. Although our data 
do not directly rule out other possible mechanisms, it is likely 
that loss of Cdk2 might be linked with changes in the length of 
G1 phase and therefore in the overall cell   cycle duration.
At variance with our fi  ndings in the adult SVZ, NG2
+ cell 
proliferation was not modifi  ed by the loss of the Cdk2 gene dur-
ing the fi  rst two postnatal weeks. In vivo and in vitro analysis 
demonstrated that both NG2
+ cell proliferation and self-renewal 
capacities were not affected in the Cdk2
−/− mouse up to P15. 
These fi  ndings not only revealed a developmentally regulated 
requirement for Cdk2 function in progenitor cells but also raised 
the important question of possible molecular differences in the 
expression and function of other cell cycle regulatory proteins 
in NG2
+ progenitors of the juvenile and adult brain.
Compensation of Cdk2 loss by Cdk4 
in SVZ progenitors is developmentally 
regulated
Western blot analysis showed that within a specifi  c set of cell 
  cycle proteins, only Cdk4 was signifi  cantly up-regulated in the 
SVZ of the Cdk2
−/− mouse at P8 as compared with the wild type. 
No differences in Cdk4 expression and kinase activity could be 
detected at P90. The time course of Cdk4 up-regulation observed 
during postnatal development of the Cdk2
−/− mouse correlated 
with the cell proliferation and self-renewal rate of SVZ progeni-
tors. Elevated levels of Cdk4 protein expression and activity in 
Cdk2
−/− tissue were observed until P15 and then subsequently 
declined at P28 and 90, when no differences in Cdk4 expression 
were observed. In the P8 and 15 Cdk2
−/− SVZ, a decreased level 
of p107 associated with E2F-4 also refl  ected higher Cdk4 kinase 
activity but no differences in the p107–E2F-4 complex were 
  observed at P28 and 90. Consistent with this, NG2
+ cell prolif-
eration and neurosphere formation were indistinguishable in 
Figure 10.  siRNA-induced knockdown of Cdk4 and 2 inhibits proliferation in P8 Cdk2
−/− and wild-type SVZ cell cultures, respectively. (A–C) Loss-
of-function experiments in perinatal SVZ cells. Cells from P8 brains were transfected with scrambled (control), Cdk4-silencing, or Cdk2-silencing siRNA and 
harvested 24 h after transfection. (A) Cell and SVZ tissue lysates were immunoblotted with anti-Cdk4 and -Cdk2 antibodies and band intensities from 
siRNA-treated cells were measured and normalized to actin. In both wild-type and Cdk2
−/− cells, a reduction of 50–70% in Cdk4 levels was obtained after 
siRNA transfection. Wild-type P8 SVZ tissue lysate was also used as a positive control for Cdk4 expression. Transfection with Cdk2 siRNA decreased Cdk2 
expression in wild-type SVZ cells by  50% but did not modify Cdk2 expression in Cdk2
−/− P8 SVZ cells. Wild-type P8 SVZ tissue lysate was also used as 
a positive control for Cdk2 expression. Black lines indicate that the intervening lanes have been spliced out. (B) Transfection of Cdk2
−/− cells with scram-
bled siRNA control did not modify neurosphere formation but Cdk4 siRNA caused a signiﬁ  cant decrease in the number of neurospheres. No effect was 
  observed in wild-type cultures. Transfection with Cdk2 siRNA reduced the number of neurospheres in wild-type cultures as compared with treatment with 
scrambled control. No effect was observed in Cdk2
−/− cells. Data were obtained from second passage neurospheres of three independent experiments. 
(C) BrdU immunolabeling showed that neural progenitor cell proliferation was impaired in Cdk2
−/− cultures after Cdk4 siRNA treatment but not in wild-type 
cultures. After Cdk2 siRNA transfection, proliferation was impaired in wild-type but not Cdk2
−/− cultures. Data represent BrdU
+ cells as percentages of total 
DAPI-labeled cells and were obtained from three separate experiments (three independent cell cultures). The total number of cells counted was 454 (scram-
bled control Cdk4), 782 (scrambled control Cdk2), 458 (Cdk4 siRNA), and 636 (Cdk2 siRNA) for the wild type; and 647 (scrambled control Cdk4), 765 
(scrambled control Cdk2), 624 (Cdk4 siRNA), and 643 (Cdk2 siRNA) for Cdk2
−/−. (D–F) Gain-of-function experiments in adult SVZ cells. Plasmid pCMV-
Cdk4 and empty vector were transfected to P90 wild-type and Cdk2
−/− cells. (D) Western blot analysis shows higher Cdk4 expression in both wild-type 
and Cdk2
−/− SVZ cells after transfection with pCMV-Cdk4 as compared with transfection with an empty vector. (E) Transfection of Cdk2
−/− cells with 
pCMV-Cdk4 caused a signiﬁ  cant increase in the number of neurospheres compared with wild-type cells. Data were obtained from second passage neuro-
spheres of three independent experiments. (F) BrdU incorporation assays. Cdk4 overexpression did not modify cell proliferation in wild-type cells but greatly 
increased cell proliferation in Cdk2
−/− cells to levels similar to the wild type. Data were obtained from three independent experiments. The total number of 
cells counted was 511 and 451 for the empty vector (wild type and Cdk2
−/−, respectively) and 425 and 608 for pCMV-Cdk4 (wild type and Cdk2
−/−, 
respectively). Data are expressed as means ± the SEM. *, P < 0.05; results were analyzed by a t-test.JCB • VOLUME 179 • NUMBER 6 • 2007  1242
Cdk2
−/− and wild-type mice up to P15 but were drastically re-
duced at P28 and 90.
To ascertain that the Cdk4 pathway could be engaged in 
compensating for the loss of Cdk2 in SVZ NG2
+ cells during 
the fi  rst two postnatal weeks (Zezula et al., 2001), we used a 
loss- and gain-of-function approach. First, we directly prevented 
Cdk4 up-regulation in cells isolated from the SVZ of Cdk2
−/− 
early postnatal brains. siRNA-mediated knockdown of Cdk4 in 
neurospheres from P8 Cdk2
−/− mice drastically decreased Cdk4 
expression levels and reduced both SVZ progenitor cell prolif-
eration and neurosphere formation. Second, we overexpressed 
Cdk4 in adult SVZ cells to compensate for its developmental 
loss. Under these conditions, both neurosphere numbers and 
cell proliferation were completely restored to wild-type levels.
In conclusion, these results indicate that Cdk4 plays an im-
portant role as a regulatory protein in compensatory mechanisms 
active during the fi  rst two postnatal weeks of the Cdk2
−/− mouse 
lifespan. We propose that these compensatory mechanisms sus-
tain NG2
+ cell proliferation and self-renewal in the SVZ during 
the fi  rst two postnatal weeks and preserve the pool of these pro-
genitors in neurogenic areas of the early postnatal brain.
Both Cdk2 and 4 are activated by their regulatory proteins 
cyclin E and D to sequentially phosphorylate Rb (Mittnacht, 
1998; Knudsen and Knudsen, 2006). Rb hyperphosphorylation 
causes dissociation of E2F transcription factors, which in turn 
activate S phase gene transcription, leading to G1/S cell cycle 
progression. Impaired neurogenesis was observed in adult mice 
lacking E2F-1 (Cooper-Kuhn et al., 2002). Because both Cdk2 
and 4 are needed for Rb activation, the question of the sequence 
of the molecular events that maintain NG2
+ cell proliferation in 
the Cdk2 null mice during the fi  rst two postnatal weeks arises. 
The Rb-like protein p107 also binds the E2F family of transcrip-
tion factors and is phosphorylated by Cdk4 but not by Cdk2 
(Beijersbergen et al., 1995). Therefore, we propose that an alter-
native cell cycle pathway active in Cdk2 null mice involves both 
Cdk4 and p107. Future experiments in cells isolated from the 
Cdk2
−/− mouse SVZ will defi  ne the specifi  c involvement of 
p107 phosphorylation in this alternative pathway.
Cdk2 involvement in neural lineage 
commitment
The decrease in NG2
+ cell proliferation observed in the adult 
SVZ may result from a shift in balance between cell prolifera-
tion and differentiation and/or cell death. Previous studies demon-
strated that Cdks as well as their inhibitors belonging to the 
Cip1/Kip1 and INK families play an essential role in regulating 
cell cycle and survival in neural tissue (Coqueret, 2003). It was 
shown that the loss of p27
Kip1 up-regulates proliferation of tran-
sient-amplifying progenitors in the SVZ concomitantly with a 
reduction in the number of neuroblasts caused by extensive apop-
tosis (Doetsch et al., 2002). Our results indicate that the loss 
of Cdk2 did not affect the number of c-Caspase3
+ cells during 
development; therefore, we exclude the possibility that apopto-
sis may have a signifi  cant impact on the regulation of the NG2
+ 
cell number in Cdk2
−/− mice.
We have previously demonstrated that NG2
+ progenitors are 
multipotential and generate oligodendrocytes and γ-aminobutric 
acid–ergic interneurons (Belachew et al., 2003; Aguirre et al., 
2004; Aguirre and Gallo, 2004; Menn et al., 2006). Consistent 
with these fi  ndings, we observed newly generated NG2
+–
Nkx2.2
+ committed oligodendrocytes and NG2
+–Dcx
+ com-
mitted neuroblasts originating from the ASVZ and migrating 
along the RMS in juvenile and adult brains. Cellular and molec-
ular analyses in vivo and in vitro demonstrate that the loss of 
Cdk2 promotes NG2
+ cell lineage commitment and differentia-
tion to oligodendrocytes and neurons in the adult SVZ. In the 
adult Cdk2
−/− but not early postnatal brain, we found an in-
creased number of fate-determined NG2
+ cells. Consistently, 
only in Cdk2
−/− neurospheres isolated from the adult SVZ did 
we observe elevated expression of mRNA encoding for cell 
type–specifi  c markers as well as an increased percentage of dif-
ferentiated neurons, oligodendrocyes, and astrocytes. These 
fi  ndings strongly support a correlation between the reduction in 
the number of uncommitted proliferating NG2
+ cells and the 
increase in differentiated phenotypes observed in the SVZ and 
RMS of the Cdk2
−/− brain.
It is known that neural differentiation is controlled by Cdk 
inhibitors, which block the activity of cyclin–Cdk complexes 
(Zindy et al., 1997; Levine et al., 2000; Coskun and Luskin, 
2001; Ohnuma et al., 2001; Zezula et al., 2001). A previous 
study indicated that p21
Cip1 acts as a positive regulator of S phase 
progression by supporting the formation of the Cdk4–cyclin D1 
complex (LaBaer et al., 1997), whereas other studies have shown 
that p21
Cip1 is required for oligodendrocyte differentiation 
  (Zezula et al., 2001). p21
Cip1 also promotes cell differentiation 
in the immune system by interaction with multiple regulatory 
proteins, including the transcription factors Stat3 and CCAAT/
enhancer binding protein (Steinman, 2002). Our data demonstrate 
an elevated expression of p21
Cip1 in adult Cdk2
−/− SVZ tissue 
in parallel with enhanced NG2
+ cell differentiation at this age, 
which suggests that p21
Cip1 might be involved in this effect.
It is known that p21
Cip1 can cooperate with other Cdk in-
hibitors, including p27
Kip1, involved in neuronal differentiation 
and fate specifi  cation of glial cells (Durand et al., 1998; Zezula 
et al., 2001). p27
Kip1 promotes neuronal differentiation of corti-
cal progenitors by stabilizing neurogenin 2 protein (Nguyen 
et al., 2006). However, p27
Kip1 expression was not modifi  ed in 
adult Cdk2
−/− SVZ, which indicates that this protein is unlikely 
to be implicated in SVZ cell differentiation in Cdk2
−/− mice.
Conclusions
Our paper identifi  es Cdk2 as an important gene for neural pro-
genitor cell proliferation and self-renewal in a major neurogenic 
region of the adult brain, the SVZ. Together with other intrinsic 
regulators, including p16
INK4a (Molofsky et al., 2006), both 
down-regulation of Cdk2 in adult tissue and the decline of a 
Cdk4-dependent compensatory mechanism appear to partici-
pate in the progressive decrease of multipotent progenitor cell 
proliferation and self-renewal potential with aging. It is likely 
that the reduced regenerative capacities that characterize aging 
SVZ progenitors may at least in part be caused by the progres-
sive Cdk2-dependent depletion of the NG2
+ progenitor pool. 
The elucidation of the critical molecular cues that control pro-
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neural progenitor cells may open new avenues for the develop-
ment of neuronal replacement therapies for neurodegenerative 
diseases and other central nervous system injuries that require 
manipulation of endogenous progenitors or transplantation of 
exogenous cells.
Materials and methods
Animals
The colony of Cdk2
−/− null mice (Berthet et al., 2003) was maintained in 
the animal facility of the Children’s National Medical Center according to the 
Institutional Animal Care and Use Committee and National Institutes of 
Health guidelines. Cdk2
−/− mice are viable and develop normally without 
any anatomical or histological malformations (Berthet et al., 2003). To breed 
Cdk2
−/− mutants, we crossed two heterozygotes because previous data 
showed that Cdk2
−/− male and female individuals are sterile. After birth, 
the newborns were genotyped according to the procedure established by 
Berthet et al. (2003) by PCR using three primers described in the supple-
mental Materials and methods (available at http://www.jcb.org/cgi/
content/full/jcb.200702031/DC1). DNA products were loaded onto 2% 
agarose gels to resolve the speciﬁ  c bands: 150 bp for the wild type, 500 bp 
for Cdk2
−/−, and both bands for heterozygotes. Heterozygote Cdk2
+/− 
mice were not analyzed in this paper.
BrdU incorporation and labeling
Proliferating cells were labeled by intraperitoneal BrdU (Sigma-Aldrich) 
  injections. P8 mice were injected with 100 μg/g BrdU once 2 h before 
being killed, whereas in adult mice (P90), 100 μg/g BrdU was given twice 
within 24 h before killing. These two different protocols of BrdU administra-
tion were based on previously described changes in the length of cell cycle 
of dividing cells throughout the lifespan (Takahashi et al., 1993; Smith and 
Luskin, 1998; Caviness et al., 2003). After BrdU injections, animals were 
anesthetized with isoﬂ  urane and transcardially perfused with 0.1 M PBS, 
pH 7.4, followed by 4% paraformaldehyde. Brains were postﬁ  xed in 4% 
paraformaldehyde overnight. Serial coronal and sagittal sections (50 μm) 
were cut using a microtome (American Optical), collected in PBS, pH 7.4, and 
stored at 4°C until use. For BrdU labeling, the tissue was pretreated with 
2 N HCl and neutralized in 0.1 M boric acid, pH 8.5. After washing, sec-
tions were incubated with primary antibody (1:50 anti-BrdU; BD Biosciences) 
overnight and then with the secondary antibody (1:200 TRITC-conjugated 
Afﬁ  niPure goat anti–mouse; Jackson ImmunoResearch Laboratories) for 1 h. 
After washing in PBS, pH 7.4, sections were mounted and analyzed by 
confocal microscopy (BX60; Olympus). Cells were scored as BrdU
+ only 
when strong immunoreactivity was clearly detected speciﬁ  cally in the nucleus 
(Figs. 2 C1 and S2).
Immunocytochemistry and cell counting
Immunocytochemistry was performed on ﬂ  oating sections using antibodies 
against the following antigens: NG2, nestin, Dcx, GFAP (all obtained from 
Chemicon), BrdU (Becton Dickinson), Ki67 (NovoCastra), Nkx2.2 (pro-
vided by T. Jessell, Columbia University, New York, NY), and c-Caspase 
(Cell Signaling Technology). All antibodies dilutions were performed as 
described previously (Aguirre et al., 2005). Sections were incubated over-
night at 4°C in primary antibodies diluted in 0.1 M PBS, pH 7.4, contain-
ing 0.1% Triton X-100 and 5% normal goat serum. Appropriate secondary 
antibodies were used as follows: TRITC-conjugated Afﬁ  niPure goat anti–
mouse IgG (H + L), FITC-conjugated Afﬁ  nitiPure goat anti–rabbit IgG, and 
TRITC-conjugated Afﬁ   niPure goat anti–mouse IgM (Jackson Immuno-
Research Laboratories). Sections were incubated with the secondary anti-
bodies for 1 h at room temperature and then mounted. For TUNEL staining, 
an apoptosis detection kit (Roche) was used according to the manufactur-
er’s instructions. Z stacks of 1-μm-thick single-plane images of the entire 
thickness of a slice were captured using a confocal microscope (MRC1024; 
Bio-Rad Laboratories) and collapsed before cell counting. Measurements 
were taken from at least 7–12 tissue sections obtained from three to four 
mice in each group. The results are presented as a mean ± the SEM and 
a t test was performed to establish statistical signiﬁ  cance.
Analysis of FACS-puriﬁ  ed NG2
+ cells
To culture a pure NG2
+ progenitor cell population, SVZs were dissected from 
wild-type and Cdk2
−/− mice at P8 and 90. Isolated cell suspensions (see Cell 
cultures and clonal analysis) were incubated with anti-NG2 antibody (1:1,000; 
Chemicon) for 1 h at 4°C. Cells were washed twice with DME/F12 medium 
supplemented with 1% N2 and 1% B27 and incubated with R-phycoerythrin 
antibody (1:5,000; CALTAG Laboratories) for 20 min at 4°C. NG2-labeled 
cells were FACS puriﬁ  ed as described previously (Inﬂ  ux; Cytopeia; Aguirre 
et al., 2005). After washing with DME/F12 medium, puriﬁ  ed NG2
+ cells 
were plated on 24-well dishes coated with poly-lysine at the density of 10 cells 
per microliter and cultured in stem cell medium (SCM; StemCell Technologies, 
Inc.) containing 20 ng/ml EGF and 10 ng/ml bFGF (Millipore). After 7 d, 
the numbers of growing neurospheres were counted in each dish.
Western blots, immunoprecipitation, and kinase activity assays
SVZs were homogenized in RIPA lysis buffer with proteinase inhibitors 
(Santa Cruz Biotechnology, Inc.). Protein extracts were boiled for 5 min be-
fore loading onto 4–20% gradient gels (20 μg of protein per each lane; 
GeneMate). Gels were electrotransferred to a 0.2-μm nitrocellulose mem-
brane (Millipore). Blots were blocked in 5% milk in TBST for 1 h and incu-
bated at 4°C overnight with one of the following antibodies: anti-Cdk2, 
-Cdk4, -Cdk6, -Cdc2, –cyclin D, –cyclin E, -p21
CIP1, -p27
KIP1 (Santa Cruz 
Biotechnology, Inc.), -p16
INK4A, -p53 (Cell Signaling Technology), and -actin 
(Chemicon). Bands were detected with appropriate HRP-conjugated second-
ary antibodies, reacted with chemiluminescent ECL substrate (GE Health-
care), and visualized by exposure to x rays. Band intensity was measured 
using the ImageJ program (National Institutes of Health). Western blots were 
obtained from the SVZ of three to four different animals in each group and 
age. Data were averaged and were represented as means ± the SEM.
For immunoprecipitation, SVZ tissue extracts from wild-type and 
Cdk2
−/− mice were prepared in RIPA buffer containing 2% Triton X-100 
and 0.2% SDS. Aliquots (270 μg of tissue) were incubated overnight with 
antibodies against E2F4 (C-20; Santa Cruz Biotechnology, Inc.) and 15 μl 
of agarose A (Santa Cruz Biotechnology, Inc.). Immunocomplexes bound to 
agarose A were collected by centrifugation and washed twice in 500 μl 
RIPA buffer containing inhibitors. Precipitated proteins were analyzed by 
immunoblotting with anti-p107 antibody (Sigma-Aldrich). Bands were de-
tected by using HRP-labeled polyclonal anti-mouse Ig (BD Biosciences) and 
developed with a chemiluminescent substrate (ECL; GE Healthcare). 
To measure Cdk4 activity, SVZ tissues were prepared as described in the 
previous paragraph. Protein extracts (350 μg) were immunoprecipitated 
with a rabbit polyclonal antibody against Cdk4 (Santa Cruz Biotechnology, 
Inc.) for 30 min at 37°C plus 18 μl of protein A–agarose (Santa Cruz 
Biotechnology, Inc.). The beads were washed twice with 500 μl of kinase 
buffer containing 1 mM DTT, 7.5 mM MgCl2, and 10 mM Tris, pH 7.4. 20-μl 
kinase reaction mixtures contained 5 μg of glutathione S-transferase–Rb 
(Santa Cruz Biotechnology, Inc.) as a substrate, 30 μM ATP, and 5 μCi 
[
32P]ATP (PerkinElmer). Reactions were stopped by adding 20 μl of 2% SDS 
loading buffer and heating at 95°C for 3 min. Labeled proteins were re-
solved on 10% mini-SDS polyacrylamide gels. Phosphorylated pRb band 
was visualized and quantitated by PhosphorImager (Molecular Dynamics).
RT-PCR
cDNA was ﬁ  rst synthesized from 1.5–2 μg of total RNA extracted from 
Cdk2
−/− and wild-type differentiated neurospheres from P8 and 90 mice 
in a total volume of 11 μl, including 10 mM dNTPmix and 0.5 μg/μl 
Oligo dT (Invitrogen). Reaction mixtures were heated at 65°C for 5 min 
and then at 42°C for 50 min. From 2 μl of cDNA, sequences of interest 
were ampliﬁ  ed in a thermocycler (Bio-Rad Laboratories) in a total volume 
of 25 μl of mixture with tag polymerase (Eppendorf). Primer pairs are 
  described in the supplemental Materials and methods. PCR products were 
resolved by vertical electrophoresis on 2% agarose gels. The intensity of 
the bands was measured using ImageJ. For the analysis of each protein, 
three to four sets of second passage neurospheres were used.
Cell cultures and clonal analysis
SVZs were dissected from 300-μm-thick brain sections prepared from P8, 
15, 28, and 90 mice and digested for 30 min at 37°C in Hanks’ balanced 
salt solution (Invitrogen) containing 13 U/ml papain (Sigma-Aldrich), 5 U/ml 
DNase (Sigma-Aldrich), and trypsin (Sigma-Aldrich). SVZ cells were disso-
ciated by trituration and resuspended in Hanks’ buffer containing 1 M 
Hepes (Invitrogen), 15% sucrose, and penicillin/streptavidin. Cells were 
then plated onto poly-L-lysine–coated dishes at a density of 10 cells per 
microliter and cultured for 10 d in DME/F-12 medium (Invitrogen) supple-
mented with 1% N2, 1% B27 (Invitrogen), 20 ng/ml EGF, and 10 ng/ml 
bFGF (Millipore). Neurospheres obtained from wild-type and Cdk2
−/− 
cells were counted and repassaged for secondary and tertiary neurosphere 
formation or, for differentiation assays, plated onto laminin-coated dishes 
(Invitrogen). Equal numbers of cells from Cdk2
−/− and wild-type mice were 
used in all experiments and were cultured under the same conditions. JCB • VOLUME 179 • NUMBER 6 • 2007  1244
For cell differentiation assays, neurospheres were cultured with 30 ng/ml 
NT3 and 10 ng/ml BDNF (Millipore). To immunolabel differentiated cells, 
standard protocols were used (Aguirre et al., 2005) with primary antibodies 
against GalC, MAP2, and GFAP (Chemicon).
siRNA-induced Cdk4 knockdown in P8 SVZ cells
Cell transfections were performed using the NeuroPORTER transfection re-
agent (Genlantis) according to the manufacturer’s instructions. After SVZ 
dissection, cells were plated in 12-well cell culture dishes at a density of 50 
cells per microliter for 24 h. At the time of transfection, cell cultures were 
 60% conﬂ  uent. Three different, commercially available siRNA sequences 
directed toward murine Cdk4 (NM-009870) and Cdk2 (AM16704) were 
obtained from Ambion. A mixture of all three siRNAs (20 pM each) pro-
duced speciﬁ  c knockdown of Cdk4 at 7 h after transfection. In brief, 2 μl 
of 20 pM of each Cdk4 siRNA solution and 12 μl of the transfection re-
agent were incubated in 100 μl of OptiMEM medium (Invitrogen) for 20 min 
to facilitate complex formation. The siRNA transfection mix was added 
to the cells cultured in 10% FBS. Control consisted of nonspeciﬁ  c siRNA 
(Silencer negative; Ambion). Cells were transfected for 7 h at 37°C, 
washed with Hanks’ buffer, and cultured in MEM with 10% FBS for an ad-
ditional 24 h. The medium was then changed to SCM (20 ng/ml EGF and 
10 ng/ml FGF). After 24 h, cells were lysed with 0.05% Trypsin-EDTA (In-
vitrogen) for 5 min and plated at a density of 10 cells per microliter in SCM 
with growth factors to generate neurospheres. 7 d later, formed spheres 
were counted in each dish and statistical analysis was performed using a 
t test. To assess the proliferative potential of cells, BrdU was added to the 
culture medium at a concentration of 10 μg/ml followed by a 60-min incu-
bation at 37°C. Cells were then ﬁ  xed in 4% paraformaldehyde and kept in 
PBS until use. BrdU incorporation was visualized by immunoﬂ  uorescence 
using an anti–mouse BrdU antibody and TRITC-conjugated Afﬁ  niPure goat 
anti–mouse IgG. Percentages of BrdU
+ cells were quantiﬁ  ed in random 
ﬁ  elds captured under 10× magniﬁ  cation (total of >250 cells) from at least 
three different samples and subjected to statistical analysis. To demonstrate 
Cdk4 and 2 knockdown, Western blots analyses were performed on trans-
fected wild-type and Cdk2
−/− cells. After transfection, cells were lysed in 
50 μl of ice-cold RIPA buffer. Protein samples were prepared and pro-
cessed as described in the Western blots, immunoprecipitation... section. 
Membranes were incubated with anti-Cdk4 and -Cdk2 antibodies and re-
sults were normalized relatively to actin.
Overexpression of Cdk4 in SVZ cells
To overexpress Cdk4 in adult SVZ cells, we used a pCMV-Cdk4 plasmid 
(van den Heuvel and Harlow, 1993) and an empty vector as a control. 
Plasmid constructs were introduced into cultured cells by liposomal trans-
fection (6 h) in 12-well dishes using 1.5 μg DNA and 12 μl of Neuro-
PORTER in SCM. After transfection, the cells were washed in SCM and 
plated on poly-lysine coated dishes for culturing (see Cell cultures and 
clonal analysis). After a 7-d analysis of neurospheres formation, BrdU 
staining and Western blotting were performed on wild-type and Cdk2
−/− 
transfected cells (as described in the previous paragraph).
Online supplemental material
Fig. S1 shows proliferation of total SVZ and RMS cells and NG2
+ progenitor 
cells after single and double BrdU injection at P90. Fig. S2 shows that loss 
of Cdk2 does not affect GFAP
+ cell proliferation in the SVZ. Fig. S3 shows 
that loss of Cdk2 does not modify the GFAP
+–nestin
+ stem cell number in 
the SVZ. Fig. S4 shows that loss of Cdk2 does not inﬂ  uence cell apoptosis 
in the SVZ. Fig. S5 shows the developmental time course of Cdk4 activity 
in the SVZ of the Cdk2
−/− mouse. Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.200702031/DC1.
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